Diagnosis of atheroembolic disease (AD) is challenging, because no specific test is available and AD often masquerades as other clinical conditions. We conducted the current study to investigate the relative frequency of autopsy-proven AD over time, to describe its clinical presentation, and to identify risk factors for AD. We screened 2066 autopsy reports from 1995 to 2006 for AD. For each AD case, a control patient without AD was matched for age, sex, and autopsy year. Diagnostic and therapeutic interventions (surgery, catheter interventions, and drug treatment) in the last 6 months before death, as well as clinical and laboratory parameters during the last hospitalization, were retrieved from electronic charts.
INTRODUCTION
A theroembolic disease (AD), also referred to as cholesterol crystal embolization, cholesterol atheroembolism, or cholesterol atheromatous embolism, was first described by Flory 4 in 1944. He reviewed 267 autopsies and found 9 cases of AD. He described ''cholesterol-crystal spaces,'' where during tissue preparation the crystals had been dissolved in the arterial lumen and an empty crystal-shaped space remained. Kassirer 11 described in 1969 2 types of histologic lesions found in AD: at an early stage ''crystals surrounded by eosinophilic material'' were found, whereas older lesions showed a thickened intima, macrophages, and multinucleated foreign-body giant cells. He also reported that fibrosis in the intima eventually obstructed the lumen completely. Only small vessels, mostly 150Y200 Km in diameter, were found to be affected.
The pathogenesis of AD has since been further analyzed: cholesterol crystals originate from the aorta in most cases, 12 but can also be released from other major arteries, as long as severe atherosclerosis is present. To release the crystals into the bloodstream, the atheromatous plaque must be eroded, thus the soft core is exposed. The contents then are flushed into distal arterial beds and trigger an inflammatory reaction, which eventually occludes the artery. Eliot et al 2 distinguished between an atheroembolus, which consists of a dislodged atheromatous plaque, big enough to clog a major artery, and a cholesterol embolus, which basically represents cholesterol crystals that occlude smaller arteries.
Cholesterol crystals can be released suddenly upon spontaneous rupture of an atheromatous plaque, but lately iatrogenic forms of the disorder have become the center of attention. Triggers are either mechanical traumaVusually surgery on arteries, 27 catheter interventions such as angiography or angioplasty 22 Vor drug interventions in the coagulation system, such as therapeutic anticoagulation 18 or thrombolysis. 5, 8, 21 The precise incidence of AD is not clear and varies in a large range depending on the risk profile of the patient group investigated. In a non-selected Dutch population, with an autopsy rate of 7%, 0.31% of autopsied patients were identified as having AD. 20 In contrast, in high-risk patient groups the incidence can increase considerably. Thurlbeck and Castleman 27 found an astonishing 77% incidence in an autopsy population that had undergone aortic aneurysm repair. Mayo and Swartz, 16 however, reported a 4% incidence among their inpatients in a renal care unit.
Clinical diagnosis of AD remains challenging, since a multitude of different symptoms has been observed and only a few nonspecific laboratory findings can help to make the diagnosis. Therefore we conducted the present study to investigate the relative frequency of autopsy-proven AD over a 12-year period, to identify risk and precipitating factors, and to facilitate diagnosis of AD through identification of clinical and laboratory features of the disease. values, imaging studies, electrocardiograms, and other specialized examinations.
For the case group (Group 1), patients had to meet the following criteria: 1) Cholesterol emboli were found in at least 1 vital organ; thereby clinical and subclinical cases were not differentiated. Cholesterol emboli were defined as ''cholesterolcrystal spaces,'' where during tissue preparation the crystals had been dissolved in the arterial lumen and an empty crystalshaped space remained. 2) Treatment before death was received at the Department of Internal Medicine at USZ, therefore all clinical and laboratory data were available there in digital or in printed form. 3) Autopsy was performed in the Department of Pathology at USZ.
For the control group (Group 2), criteria were the following: 1) No cholesterol emboli were found at autopsy. Criteria 2) and 3) from above were also applied for Group 2. Furthermore, control patients were matched to case patients for sex, age, and autopsy year in a 1:1 ratio. Two patients with AD were not matched to a control patient because they arrived at the emergency room in cardiac arrest, so few clinical data and no laboratory features were available for analysis.
Pathologists performed all autopsies according to a standardized procedure, and all organs were systematically examined and analyzed by histology.
For all case and control patients we systematically recorded data about demographics, comorbidities, clinical manifestations of AD, and precipitating factors during the last 6 months before death. 23, 25 These data were retrieved from an electronic chart database and manually checked where necessary. Data on the highest recorded laboratory values were collected for the period of the last hospital stay before death. The cause of death was determined by the clinical and pathology reports.
Presence of risk factors for atherosclerosis such as hypertension, hypertriglyceridemia or hypercholesterolemia, and diabetes were assumed when either a respective medication was prescribed or the diagnosis appeared in the medical history. In addition we checked laboratory records for information on blood lipids. Hypercholesterolemia was defined by total cholesterol levels 9190 mg/dL, and hypertriglyceridemia by total triglyceride levels 9150 mg/dL. 6 Tobacco abuse was recorded when a history of smoking of a minimum of 5 pack years was known, without distinguishing between current, recent, or earlier tobacco use. Acute renal failure was registered when the serum creatinine level doubled from baseline, according to an adapted classification of the Acute Kidney Injury Network. 17 Chronic kidney failure was defined as either kidney damage or decreased kidney function for at least 3 months. 14 We also collected data to calculate the relative AD frequency per year in autopsies, biopsies, and clinical cases observed in the Department of Internal Medicine at USZ. Information on total number of autopsies and biopsies with and without AD was retrieved from the electronic database of the Department of Pathology, whereas the total number of clinically suspected cases and the total number of inpatient discharges at the Department of Internal Medicine were retrieved from an electronic chart system by full text searches of discharge reports.
The ethics committee for clinical studies of the Canton of Zürich approved this study.
Statistical Analysis
Descriptive statistics were computed. Results are presented as means T standard deviation and relative frequency. To skewed continuous variables such as blood serum creatinine, blood urea nitrogen, C-reactive protein, lactate dehydrogenase, and pancreatic amylase, logarithmic transformation was applied. First, univariable and multivariable logistic regression for case/control was computed. Next, univariable and multivariable conditional logistic regression analysis was performed to control for matching in the data. A p value of e 0.05 was considered statistically significant. To compare relative frequencies, we used the Wilson method for the computation of 95% confidence intervals (CI) for the difference of true proportions. All data were analyzed with SPSS version 16.0 for Macintosh. Conditional logistic regression was performed with STATA Version 10 for Macintosh. Graphs were generated in PowerPoint and Excel.
RESULTS
Among 2066 autopsies performed between 1995 and 2006, we found 51 patients with autopsy-proven AD, resulting in a relative frequency of 2.5% in this particular population. It is noteworthy that of those 51 patients, AD had been diagnosed in only 6 (12%) before death.
Autopsy Findings in AD Cases
We first analyzed the number of affected organs in each patient ( Figure 1A ). Among the 51 patients with AD, 22% (11/51) showed involvement of more than 2 organs, with up to 5 organs in 2% (1/51). If we further assumed that clinically typical skin manifestations were indeed symptoms of AD (even without histologic confirmation), the percentage of patients with more than 1 organ affected rose to 61%. Thus, AD was a multisystem disorder in the majority of cases.
When we analyzed the type of organs involved ( Figure 1B) , the kidneys were most often affected (36/51 patients; 71%), confirming earlier findings. 13 The kidney was followed by spleen, lower gastrointestinal tract, and pancreas. The group labeled BOthers[ in Figure 1B includes various organs rarely affected by AD. Among those 6 patients, we found cholesterol emboli in the brain (2 patients), adrenal glands (2 patients), thyroid gland (1 patient), and penis (1 patient). The last patient presented with balanitis. As this was clinically a persisting problem, at autopsy a sample of the penis was taken, revealing an atheroembolus.
Baseline Characteristics and Risk Factors of AD Patients and Controls
In the current series of AD patients, 75% were male, and all but 1 were aged above 53 years (mean age, 71 T 11 yr). One patient, who was younger than 30 years, had suffered from congenital heart disease. All patients were white, with the exception of 1 Asian woman. The mean body mass index was 25.5 T 4 kg/m 2 .
For further analysis of risk factors, 49 AD patients were matched to a control group for age, sex, and autopsy year ( Table 1) . Two AD patients were not matched, because they arrived dead in the hospital. In both groups 98% had atherosclerosis documented by autopsy. The autopsy of the 27year-old patient did not reveal any generalized atherosclerosis of major arteries except 1 area on the aortic root, where atherosclerotic changes were found. We must assume this was the source of the emboli. In Group 1, 51% (25/49) of patients had diabetes, whereas in the control group, only 33% (16/49) had diabetes (p = 0.07).
Angiography with or without angioplasty was found to be a highly significant risk factor for AD in univariable analysis (odds ratio EOR^, 3.5; 95% CI, 1.30Y9.36; p = 0.01), and even in conditional multivariable logistic regression when controlling for matching, it remained significantly associated with AD (OR, 3.2; 95% CI, 1.02Y9.98; p = 0.05). Extensive surgery ( joint replacement or opening of a body cavity) also represented a major risk factor for AD in univariable analysis and in conditional univariable logistic regression (OR, 3; 95% CI, 1.19Y7.56; p = 0.02), revealing no matching influence.
In 22% (11/49) of patients, none of these conditionsV angiography, angioplasty, surgery on arteries, or therapeutic anticoagulationVhad taken place in the last 6 months before death. In these patients AD probably occurred spontaneously. However, we cannot exclude that any one of these interventions had occurred more than 6 months before death, that is, before the recording of our data.
Presentation of AD: Clinical Signs and Symptoms
In our series of AD patients, involvement of the skin occurred in 33% (16/49) of cases (Table 2) . At examination either livedo reticularis or ''blue toe'' was found. Skin manifestations were significantly associated with AD in univariable analysis (OR, 2.91; 95% CI, 1.07Y7.90; p = 0.04). Results of the univariable conditional logistic regression were no longer significant (p = 0.07).
Acute onset of renal failure was documented in 45% (22/49) of AD patients, but this number was even slightly higher in the control group, in which 55% (27/49) were affected. In contrast, pre-existing chronic renal failure was slightly more common among AD patients (61% E30/49^vs. 47% E23/49^), although this difference was not statistically significant (p = 0.16).
Cholesterol emboli in retinal arteries, the so-called Hollenhorst plaques, were found in 1 patient. Unfortunately, only 6% (3/49) of AD patients underwent examination of the eye fundi. Taking all the charts into consideration, eye examination was reported in 5% (5/98) of the patients only. 
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Presentation of AD: Laboratory Findings
Only 59% (58/98) of all reviewed charts contained urinalysis results. Hematuria was classified positive with Q2+ by dipstick. In univariable analysis hematuria was significantly associated with the control group (OR, 0.26; 95% CI, 0.08Y0.88; p = 0.03) ( Table 2 ). However, in conditional logistic regression when controlling for matching, it was no longer significant (p = 0.14). Proteinuria was graded positive if the dipstick showed Q1+. It showed a tendency for association with AD, although it did not reach significance (p = 0.07) in univariable analysis. Overall kidney function did not differ between the 2 groups: the mean value of the peak serum creatinine was 3.04 T 2.22 mg/dL in AD patients and 2.94 T 1.83 mg/dL in controls.
Eosinophilia has been reported to be frequently associated with AD. 1, 7, 10, 16, 23 In our patient population, absolute eosinophil counts were available for 64 patients. Eosinophil counts above 500/KL were found in 17% (7/41) of AD patients, but only 6% (2/32) of controls. This yielded an OR 93, which, however, was not significant (p = 0.18). Thus, we conclude that presence of eosinophilia should raise a high clinical suspicion of AD, although its absence cannot exclude it.
The optimal multivariable logistic regression was found to have 2 predictors: C-reactive protein (OR, 0.995; 95% CI, 0.991Y0.999; p = 0.019), which was available for all cases and controls; and angiography (OR, 4.1; 95% CI, 1.46Y11.75; p = 0.007). Conditional logistic regression also revealed that Creactive protein (OR, 0.996; 95% CI, 0.99Y1; p = 0.09) and angiography (OR, 3.2; 95% CI, 1.02Y9.98; p = 0.045) were significantly associated with AD, therefore excluding any matching influence. Based on the ORs among these 2 parameters, only angiography was considered clinically significant.
Causes of Death
One patient clearly died from extensive AD: 5 of his organs were affected in addition to typical skin lesions, and the disease led to acute renal failure. Overall, 69% (35/51) of patients in Group 1 died from cardiovascular causes, and AD may have played a role to a variable extent. The main other causes of death were sepsis in 16% (8/51) and neoplasia in 12% (6/51). In comparison, the causes of death in Group 2 were cardiovascular in 49% (24/49), sepsis in 29% (14/49), and neoplasia in 22% (11/49). Thus, a tendency for a higher incidence of cardiovascular death was found in the AD group (OR, 2.28; p = 0.05)
Relative Frequency of AD Over Time in Autopsy, Biopsy, and Clinical Diagnosis
We first analyzed the relative frequency of AD per 100 autopsies in each year of the 12-year period from 1995 to 2006 and surprisingly found a decrease from 3.5 to 0.5 per 100 autopsies ( Figure 2A ). This, however, was not statistically significant: the 95% CI for the difference of true proportions between years 1995 and 2006 (j0.018, 0.06) revealed no difference in the relative frequencies between both years. During the same time, the overall number of autopsies had also declined. However, the median age of autopsied patients for the years 1995, 2000, and 2006 remained stable at 64.5 years, therefore not indicating any severe selection bias over time. Furthermore, differences in autopsy techniques could be excluded, as those standards have not changed over the years.
To evaluate whether this decline of AD in autopsy represents a real decline of the occurrence of disease in our observation period, we analyzed the relative frequency of biopsy-proven AD ( Figure 2B ) and of clinical AD diagnoses ( Figure 2C ) during the same time period in the Department of Internal Medicine at USZ. The former was normalized to the total number of biopsies, the latter to the total number of discharges of the respective year. For both analyses the relative frequency was stable over time.
DISCUSSION
AD occurred at a frequency of 2.5% in a large autopsy series from patients deceased in the Department of Medicine of a major Swiss university hospital between 1995 and 2006. Due to a possible selection bias in the patient population of a tertiary care hospital, which admits a higher percentage of severely ill patients compared to other hospitals, this frequency may not be extrapolated directly to the general population. Of interest, AD was frequently missed clinically, since only 12% of the AD cases detected by autopsy were diagnosed antemortem. The relative frequency of autopsy-proven AD had a tendency to decrease over time, whereas diagnoses of AD on biopsies and clinical diagnoses remained constant. We compared our study cohort with the cohorts of 4 previous studies ( Table 3 ). The table reveals a high variability in frequency of risk factors and symptoms of AD, which may partially reflect the use of different selection criteria, but also reflects the high variability of clinical presentation of this disease.
Angiography and major arterial surgery have been reported as 2 major risk factors for AD, especially in elderly patients with suspected atherosclerosis. 22, 27 The current study confirmed this for angiography with a high significance even in multivariable analysis. During either of these 2 interventions, mechanical manipulation of blood vessels causes atheroembolic plaques to disrupt, and subsequently this debris might clog smaller peripheral arteries. In case of extensive extra-arterial surgery, such as a joint replacement or the opening of a body cavity, stress or pain-related hypertension can cause shear forces that can promote atheromatous plaque rupture. In addition, anticoagulants, which are given to prevent postoperative thrombosis, are also known to favor AD. 18 However, the prophylactic use of anticoagulants after surgery was not a significant risk factor for AD in our study population.
Not every histologic finding of cholesterol crystals in tissues leads to a clinically relevant disease manifestation. Therefore retrospective data derived from autopsy or biopsy studies may exaggerate AD frequency. 24 Nevertheless, AD remains highly underdiagnosed, and remains a marker of high Fries et al atherosclerotic burden and therefore cardiovascular risk. In our autopsy collective, 88% were clinically missed, although almost all presented with typical risk factors and 33% had either livedo reticularis or blue toe as common skin symptoms. In our study cutaneous manifestations were significantly associated with AD. With 33%, the proportion is similar to earlier studies. 3 In contrast, recent studies report skin manifestations in 88%Y96%, 1, 9, 24 most likely because lesions were systematically looked for and even subtle signs were recorded. Skin symptoms can first appear within a month after the intervention, 15, 25 and might be better visible if the patient is in an upright position. 9 Biopsy confirms the diagnosis. If biopsy specimens are not taken too superficially, 18 sensitivity reaches 86%. 9 Besides a variety of symptoms, which often are not conclusive, few laboratory features help to make the diagnosis of AD. Eosinophilia has been shown to be present for 2Y3 days in early stages of the disease, and therefore can be easily missed. 10 In contrast, Thériault et al 26 stated that eosinophilia was present more than 1 month after AD diagnosis. This leads to the assumption that the presence of eosinophilia is alternating over a long period of time. The fact that this finding has been reported in several other studies 1, 7, 10, 16, 23 with varying percentages between 44% and 100% reinforces this theory. In our series, we must assume that eosinophilia was missed in several other cases, because our study did not include long-term surveillance, nor were eosinophil counts collected regularly, both measures necessary to comply with the episodic appearance of eosinophilia.
The kidney is often targeted in AD. Scolari et al 24 suggested that the proximity to the abdominal aorta and the large renal blood supply are the reasons for the frequent involvement. In our series, 71% of the examined kidney samples showed the typical crystal-shaped clefts. This may have led to the higher percentage of chronic renal disease and proteinuria in Group 1. Indeed, urinalysis might give helpful clues toward diagnosis of AD. The search for proteinuria should be performed, as this has been observed regularly in AD patients. 7, 25 Greenberg et al 7 stated that 2 distinct populations among AD patients exist, and that, in those patients with heavy proteinuria (38% in their series), focal segmental glomerulosclerosis with capillary loop collapse was found in 78%.
Although the incidence of AD is reported to be less than 5%, 13, 16, 20 mortality and especially morbidity, as well as the economic impact of the disease, are considerable. 9, 13 Thus timely diagnosis is required and can be achieved with a high level of clinical suspicion. White men, aged older than 50 years, who present with classical symptoms and risk factors of advanced atherosclerosis are prone to suffer from this medical condition. 23 When undertaking any kind of intervention on arteries, monitoring for AD should take place. Common findings of AD are blue toe, livedo reticularis, or renal failure. But AD can also cause pancreatitis, muscle pain, gastrointestinal bleeding, hypertension, peptic ulcer, and inflammatory bowel disease, 19 as well as prostatitis and hemorrhagic cystitis. 20 Therefore AD often masquerades as presumed other clinical conditions. Even the balanitis in 1 of our patients might have occurred as a consequence of AD. Moolenaar et al 20 reported to have ''observed singular reports of cholesterol crystal embolization in connection with skin hyperplasia and atrophy,...lichen ruber planus, preputial ulcer, and basalioma.'' If a patient is diagnosed with this disease, early and aggressive therapy should be initiated, since the prognosis for renal and patient survival is dismal when multivisceral involvement occurs. 1 One therapy approach by Belenfant et al 1 aimed to prevent the 3 major causes of death in AD according to earlier studies: ''recurrence of cholesterol crystal embolization, cardiac failure and cachexia.'' Those authors used a combination of blood pressure-lowering agents, hemodialysis, nutritional support, corticosteroids, discontinuation of anticoagulation treatment, and no further use of any intra-arterial interventions. Corticosteroids were administered in low doses, and improvements in clinical status, as well as pain relief, were reported. 1 However, the use of corticosteroids remains controversial. Scolari et al, 23 when reporting their multicenter study on 354 patients in 2007, stated that no difference in outcome was noted when giving steroids. A surgical approach for the management of affected patients has also been discussed in the past. After surgical removal of the sources of atheroemboli, a lower morbidity and less recurrence of AD, as well as better outcome considering limb loss, was observed, but this finding did not apply to the suprarenal aorta, which is believed to be the main source of thrombi. 12 However, with still limited therapy options, no causal treatment available, and high morbidity, prevention of AD must be the first priority. The current matched-pair autopsy study demonstrates that AD is still frequently missed in over 80% of the cases. Typical skin lesions and a history of atherosclerosis or arterial interventions should raise a high level of clinical suspicion and should lead to simple clinical exams (such as looking for Hollenhorst plaques in the eye fundi) and screening for organ dysfunction (such as renal failure).
